» Articles » PMID: 36382305

Ferroptosis-based Nano Delivery Systems Targeted Therapy for Colorectal Cancer: Insights and Future Perspectives

Overview
Date 2022 Nov 16
PMID 36382305
Authors
Affiliations
Soon will be listed here.
Abstract

There are limited options for patients who develop liver metastasis from colorectal cancer (CRC), the leading cause of cancer-related mortality worldwide. Emerging evidence has provided insights into iron deficiency and excess in CRC. Ferroptosis is an iron-dependent form of programmed cell death characterized by aberrant iron and lipid metabolism, which play crucial roles in tumorigenesis, tumor progression, and treatment options. A better understanding of the underlying molecular mechanism of ferroptosis has shed light on the current findings of ferroptosis-based nanodrug targeting strategies, such as driving ferroptosis in tumor cells and the tumor microenvironment, emerging combination therapy and against multidrug resistance. Furthermore, this review highlights the challenge and perspective of a ferroptosis-driven nanodrug delivery system for CRC-targeted therapy.

Citing Articles

Nonviral targeted mRNA delivery: principles, progresses, and challenges.

He X, Li G, Huang L, Shi H, Zhong S, Zhao S MedComm (2020). 2025; 6(1):e70035.

PMID: 39760110 PMC: 11695212. DOI: 10.1002/mco2.70035.


Advances in molecular imaging and targeted therapeutics for lymph node metastasis in cancer: a comprehensive review.

Wu Y, Shang J, Zhang X, Li N J Nanobiotechnology. 2024; 22(1):783.

PMID: 39702277 PMC: 11657939. DOI: 10.1186/s12951-024-02940-4.


Mapping the evolution and research landscape of ferroptosis-targeted nanomedicine: insights from a scientometric analysis.

Cao S, Wei Y, Yue Y, Wang D, Yang J, Xiong A Front Pharmacol. 2024; 15:1477938.

PMID: 39386034 PMC: 11461269. DOI: 10.3389/fphar.2024.1477938.


Research progress of ferroptosis regulating lipid peroxidation and metabolism in occurrence and development of primary liver cancer.

Shu Y, Lao B, Qiu Y World J Gastrointest Oncol. 2024; 16(6):2335-2349.

PMID: 38994128 PMC: 11236230. DOI: 10.4251/wjgo.v16.i6.2335.


Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy.

Sheikh A, Kesharwani P, Almalki W, Salman Almujri S, Dai L, Chen Z Nanomicro Lett. 2024; 16(1):188.

PMID: 38698113 PMC: 11065855. DOI: 10.1007/s40820-024-01399-0.


References
1.
Li L, Qiu C, Hou M, Wang X, Huang C, Zou J . Ferroptosis in Ovarian Cancer: A Novel Therapeutic Strategy. Front Oncol. 2021; 11:665945. PMC: 8117419. DOI: 10.3389/fonc.2021.665945. View

2.
Ma S, Henson E, Chen Y, Gibson S . Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis. 2016; 7:e2307. PMC: 4973350. DOI: 10.1038/cddis.2016.208. View

3.
Liu Y, Bhattarai P, Dai Z, Chen X . Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2018; 48(7):2053-2108. PMC: 6437026. DOI: 10.1039/c8cs00618k. View

4.
Demuynck R, Efimova I, Naessens F, Krysko D . Immunogenic ferroptosis and where to find it?. J Immunother Cancer. 2021; 9(12). PMC: 8671998. DOI: 10.1136/jitc-2021-003430. View

5.
Giraldo N, Sanchez-Salas R, Peske J, Vano Y, Becht E, Petitprez F . The clinical role of the TME in solid cancer. Br J Cancer. 2018; 120(1):45-53. PMC: 6325164. DOI: 10.1038/s41416-018-0327-z. View